Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions (STRIKE-CTO)
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions; Systemic Chronic Total Occlusion Revascularization Korea Research-Chronic Total Occlusion (STRIKE-CTO) Study
Sponsor: Abbott Medical Devices
Listed as NCT03667196, this observational or N/A phase trial focuses on Chronic Total Occlusion of Coronary Artery and remains actively recruiting participants. Sponsored by Abbott Medical Devices, it has been updated 10 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jul 2023 — Dec 2023 [monthly]
Recruiting
-
Apr 2023 — Jul 2023 [monthly]
Recruiting
-
Jan 2021 — Apr 2023 [monthly]
Recruiting
-
Dec 2018 — Jan 2021 [monthly]
Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Recruiting
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Biotronik SE & Co. KG
- Dio Medical
- Medtronic
- Seung-Whan Lee, M.D., Ph.D.
For direct contact, visit the study record on ClinicalTrials.gov .